MedTrace Logo

Effects of Oral Magnesium Supplementation on Patients With Type 2 Diabetes

NCT04636411 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-02-07

No results posted yet for this study

Summary

A total of 74 Adult Patients with type 2 diabetes mellitus (T2D) will be enrolled and randomized into 2 groups. The intervention group will receive oral magnesium (Mg) supplementation. The study objectives are:

1. To estimate level of Mg (total and ionized) in patient with type 2 DM.
2. To determine the effect of Mg supplementation for diabetic patient on serum Mg level, glycemic control and level of inflammation.
3. To assess the correlation between serum Mg level and glycemic control and level of inflammatory mediators (CRP)

Conditions

  • Type2 Diabetes

Interventions

DIETARY_SUPPLEMENT

Oral Magnesium Supplementation

250 mg of elemental magnesium daily for three months

OTHER

Standard Care for diabetic patients

Health education, oral antihyperglycemic medications according to American Diabetes Association (ADA) guidelines

Sponsors & Collaborators

  • Walaa Reda Abdel Fattah Mohamed Badr

    collaborator UNKNOWN

  • Marwa Mostafa Ahmed

    collaborator UNKNOWN

  • Moushira Hosny Ezzelarab Sayed

    collaborator UNKNOWN

  • Nagwa Eid Sobhy Saad

    collaborator UNKNOWN

  • Samar Fares, MD

    lead OTHER

Principal Investigators

  • Nagwa E Saad, Professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-10-31
Completion
2021-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04636411 on ClinicalTrials.gov